Theragenics Brachytherapy Recognizes Prostate Cancer Awareness Month with the “I Know My PSA. Do You?” Movement September 17, 2026
New BXTA white paper reinforces the role of focal LDR brachytherapy in localised prostate cancer June 12, 2026
Theragenics and Clarity Pharmaceuticals Partner to Enable Scalable Copper-64 Supply for Next-Generation Diagnostics March 25, 2026
Randomized Trial Supports Dose-De-Escalated Pd-103 LDR Brachytherapy for Low-Risk Prostate Cancer January 7, 2026
Theragenics Brachytherapy is headed to the 36th Annual International Prostate Cancer Update December 5, 2025
ABS GYN and Prostate Brachytherapy Hands-On Workshop from Fundamentals to Advanced Practice September 15, 2025
